Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

No treatment fully prevents hair loss from chemotherapy yet.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

Future acne treatments should aggressively target inflammation to prevent scarring.

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

lncRNA XLOC_008679 and gene KRT35 affect cashmere fineness in goats.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

PCOS is a long-term condition that needs more research for better understanding and treatment.